Skip to content

Cognitive Function and Brain Connectivity in CAS Patients:a Rs-fMRI Study

Cognitive Function and Brain Connectivity in Carotid Artery Stenting Patients:a Rs-fMRI Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05292729
Enrollment
30
Registered
2022-03-23
Start date
2021-12-01
Completion date
2022-07-01
Last updated
2022-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carotid Artery Stenosis, MRI, Functional

Keywords

resting state, MRI, carotid artery stenting, cognition

Brief summary

This is a prospective study aimed to explore the changes of cognitive function after surgery for CAS and the correlation with brain connectivity, in order to look for the clinical biomarkers to predict the carotid stent implantation for patients which can effect the cognition

Detailed description

Carotid artery stenting (CAS) can significantly decrease the incidence of ischemic stroke in patients with severe carotid artery stenosis has been confirmed in large randomized controlled studies (1, 2).Previous studies showed carotid artery stenosis is closely related to cognitive dysfunction, including asymptomatic carotid artery stenosis(≥70%).Cognitive impairment is one of the most serious problem facing the elderly. The impact on cognitive function in patients with CAS has been discussed by many researchers, however the effect still remained conflicting. In past few years, several imaging techniques, such as resting-state functional MRI (R-fMRI), had been increasingly used to study cognitive impairment in humans. In this study, we evaluated the cognition performance in severe carotid artery stenosis patients undergoing CAS and explored the mechanisms underlying the cognition changes by the Rs-fMRI. Inclusion criteria: * age between 55 years and 80 years * unilateral internal carotid artery stenotic degree ≥ 70% * right-hand-dominant * free of dementia, and depression * modified Rankin Scale: 0 or 1 * education ≥6 years * obtained written informed consent. Exclusion criteria: * contralateral internal carotid artery stenosis ≥ 50% * posterior circulation diseases * MMSE \< 26, which is a cut-off value for mild cognitive impairment * severe systemic diseases and neuropsychiatric diseases (such as congestive heart failure) * any contraindications for MRI scan (e.g., metal implants) * Non atherosclerotic stenosis, such as dissection, vasculitis.

Interventions

None listed

Sponsors

First Affiliated Hospital of Zhejiang University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
55 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* age between 55 years and 80 years * unilateral internal carotid artery stenotic degree ≥ 70% * right-hand-dominant * free of stroke, TIA, dementia, and depression * modified Rankin Scale: 0 or 1 * education ≥6 years * obtained written informed consent.

Exclusion criteria

* contralateral internal carotid artery stenosis ≥ 50% * posterior circulation diseases * MMSE \< 26, which is a cut-off value for mild cognitive impairment * severe systemic diseases and neuropsychiatric diseases (such as congestive heart failure and history of stroke) * any contraindications for MRI scan (e.g., metal implants)

Design outcomes

Primary

MeasureTime frameDescription
Montreal Cognitive Assessment, MOCAbefore CAS(within 1 week)use MOCA to assess the cognition before CAS
Mini-mental State Examination,MMSEbefore CAS(within 1 week)use MMSE to assess the cognition before CAS

Secondary

MeasureTime frameDescription
Digit Symbol Testbefore CAS(within 1 week)use to assess the cognition before CAS
Trail Making Test A/Bbefore CAS(within 1 week)use to assess the cognition before CAS
digital span testbefore CAS(within 1 week)use to assess the cognition before CAS

Countries

China

Contacts

Primary ContactRenjie Ji, Master
zjujirenjie@zju.edu.cn+86 13738101002
Backup ContactHanfeng Chen, Master
chf0106@foxmail.com+86 18768115416

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026